نتائج البحث

Safety Signal of Clopidogrel and the Risk of Hypertension تحذيرات السلامة

CEF cells from SPF eggs/ HVT IBD قائمة الأدوية تحت التسجيل / قائمة الأدوية المعروضة على لجنة التسجيل

Safety Signal of Hypokalemia associated with the use of Ceftriaxone تحذيرات السلامة

Follow-up of Phase I/II study of CaspaCIDe T cells (BPX-501) from an HLA-partially matched family donor after negative selection of TCR αβ+T cells in pediatric patients affected by hematological disorders قائمة الدراسات السريرية المسجلة على الادوية

The Canadian Minister of International Trade Visits SFDA خبر

CAMBRIA-2: A Phase III, Open-Label, Randomised Study to Assess the Efficacy and Safety of Camizestrant (AZD9833, a Next Generation, Oral Selective Estrogen Receptor Degrader) Versus Standard Endocrine Therapy (Aromatase Inhibitor or Tamoxifen) as Adjuvant Treatment for Patients with ER+/HER2- Early Breast Cancer and an Intermediate-High or High Risk of Recurrence Who Have Completed Definitive Locoregional Treatment and Have No Evidence of Disease قائمة الدراسات السريرية المسجلة على الادوية

"Study H9X-MC-GBGC is a Phase 3, randomized, double-blind, placebo-controlled trial withan open-label extension that investigates the effect of the addition of dulaglutide (0.75 and1.5 mg/week) or placebo weekly to metformin and/or basal insulin on change from baselinein hemoglobin A1c at 26 weeks in children and adolescents with type 2 diabetes mellitus" قائمة الدراسات السريرية المسجلة على الادوية

26th GHWP Annual Meeting and 26th TC Meeting مقال

LIDOCAINE (LIGNOCAINE) HYDROCHLORIDE, EPINEPHRINE 26/4/2021 سجل الأدوية

Multicenter, first-line metastatic open-label prospective phase II trial evaluating the combination of Palbociclib (CDK 4/6 Inhibitor) and hormone therapy (Letrozole or Anastrozole) in women with luminal, HER2 negative advanced breast cancer: Evaluation of the prediction of individual treatment efficacy using infrared laser spectroscopy analysis on liquid biopsies (Quantum Optics) قائمة دراسات سريرية

عرض 81 - 90 من 4767